Mitral Regurgitation - Valvular Heart Disease Guidelines

Valvular Heart Disease

ACC/AHA Valvular Heart Disease - Mitral Regurgitation GUIDELINES Apps brought to you charge courtesy of Guideline Central and Abbott Vascular.

Issue link: https://eguideline.guidelinecentral.com/i/362036

Contents of this Issue

Navigation

Page 43 of 59

42 Infectious Endocarditis Figure 8. Recommendations for Imaging Studies in NVE and PVE a Repeat TEE and/or TTE recommended for re-evaluation of patients with IE and a change in clinical signs or symptoms and in patients at high risk of complications. Blood cultures × 2 TEE a (I) TEE (IIa) Cardiac CT (IIa) TEE (IIb) Intraoperative TEE (I) Nondiagnostic TTE Complications present or suspected Intracardiac lead present S. aureus bacteremia without known source Prosthetic valve with persistent fever Suspected paravalvular infection with inadequate TTE/TEE Nosocomial S. aureus bacteremia with portal of entry from known extracardiac source Undergoing surgery for IE TTE Patient at Risk or With Suspected NVE or PVE

Articles in this issue

view archives of Mitral Regurgitation - Valvular Heart Disease Guidelines - Valvular Heart Disease